BioCentury
ARTICLE | Financial News

Gilead to split shares

January 19, 2001 8:00 AM UTC

GILD's board approved a 2-for-1 split of the company's shares, effective Feb. 21 for shareholders of record as of Feb. 2. GILD is developing therapeutics for cancer and infectious diseases. ...